Search results
Results From The WOW.Com Content Network
Top surgery involves more than a mastectomy for the treatment of breast cancer. [1] Special techniques are used to contour and reduce the chest wall, position the nipples and areola, and minimize scarring. [1] If the breast size is small, surgery that spares the skin, nipple and areola (subcutaneous nipple-sparing mastectomy) may be performed ...
v. t. e. Masculinizing hormone therapy, also known as transmasculine hormone therapy or female-to-male (or FTM) hormone therapy, is a form of hormone therapy and gender affirming therapy which is used to change the secondary sexual characteristics of transgender people from feminine or androgynous to masculine. [ 1][ 2][ 3] It is a common type ...
Breast cancer can metastasize anywhere in body but primarily metastasizes to the bone, lungs, regional lymph nodes, liver and brain, with the most common site being the bone. [4] Treatment of metastatic breast cancer depends on location of the metastatic tumors and includes surgery, radiation, chemotherapy, biological, and hormonal therapy. [5]
Brian Czerniecki, MD, a surgical oncologist at Moffitt Cancer Center, agrees. “For years, we have known that there is no survival benefit to bilateral mastectomy,” he says. “Most do it for ...
v. t. e. Gender-affirming surgery for male-to-female transgender women or transfeminine non-binary people describes a variety of surgical procedures that alter the body to provide physical traits more comfortable and affirming to an individual's gender identity and overall functioning. Often used to refer to vaginoplasty, sex reassignment ...
Gender-affirming surgery is a surgical procedure, or series of procedures, that alters a person's physical appearance and sexual characteristics to resemble those associated with their identified gender. The phrase is most often associated with transgender health care and intersex medical interventions, although many such treatments are also ...
[337] [334] There is no evidence that breast cancer risk in transgender women is greater than in cisgender women. [338] Twenty cases of breast cancer in transgender women have been reported as of 2019. [334] [339] Cisgender men with gynecomastia have not been found to have an increased risk of breast cancer. [340]
High-dose chemotherapy and bone marrow transplant ( HDC/BMT ), also high-dose chemotherapy with autologous bone marrow transplant ( HDC/ABMT or just ABMT ), was an ineffective treatment regimen for metastatic breast cancer, and later high-risk breast cancer, that was considered promising during the 1980s and 1990s.